Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Assess the Preliminary Efficacy and Safety of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Genetic Obesities

NCT05532020 is registered in ClinicalTrials.gov with Soleno Therapeutics, Inc. as lead sponsor.

NCT NCT05532020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Assess the Preliminary Efficacy and Safety of DCCR (Diazoxide Choline) Extended-Release Tablets in Patients With Genetic Obesities
Lead sponsor
Soleno Therapeutics, Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
January 31, 2023
Completion date
March 31, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity associated with pcsk1 mutation (rs6232 variant), sh2b1 deficiency obesity, sim1 deficiency obesity